GSK’s oral antibiotic Blujepa (gepotidacin) has been approved by the US Food and Drug Administration (FDA) to treat ...

Fox&Cat has announced the appointment of Kim Walker (pictured left) as partner and managing director. Walker brings over two ...

The US Food and Drug Administration (FDA) has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release ...

“Right now, only 20% of patients with EGFR-positive NSCLC survive beyond five years,” explained Joshua Bauml, vice president, ...

In fact, I said (closing my answer with a Niall Ferguson quote), ‘the law of intended consequences is the only real law of ...

Fox&Cat appoints Kim Walker as Partner and Managing Director, bringing leadership strength and operational focus to the ...

The UK Health Security Agency (UKHSA) has released a new reference tool to help guide preparedness efforts against the ...

Sanofi’s tolebrutinib has been accepted for priority review by the US Food and Drug Administration (FDA) to treat certain ...

Merck & Co – known as MSD outside the US and Canada – has said it will be gaining exclusive global rights to Jiangsu Hengrui ...

It pays to strive for KAM excellence Veeva analysis shows that while alignment is generally good, key accounts are often ...

GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...

What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at ...